He II heat exchanger test unit for the LHC inner triplet
The Inner Triplet Heat Exchanger Test Unit (IT-HXTU) is a 30-m long thermal model designed at Fermilab, built in US industry, fully automated and tested at CERN as part of the US LHC program to develop the LHC Interaction Region quadrupole system. The cooling scheme of the IT-HXTU is based on heat exchange between stagnant pressurized He II in the magnet cold mass and saturated He II (two-phase) flowing in a heat exchanger located outside of and parallel to the cold mass. The purposes of this test are, among others, to validate the proposed cooling scheme and to define an optimal control strategy to be implemented in the future LHC accelerator. This paper discusses the results for the heat exchanger test runs and emphasizes the thermal and hydraulic behavior of He II for the inner triplet cooling scheme.
HEAT EXCHANGER DESIGN STUDIES FOR AN LHC INNER TRIPLET UPGRADE
A luminosity upgrade of the CERN Large Hadron Collider (LHC) is planned to coincide with the expected end of life of the existing inner triplet quadrupole magnets. The upgraded inner triplet will have much larger heat loads to be removed from the magnets by the cryogenics system. A number of cryogenics design studies have been completed under the LHC Accelerator Research Program (LARP), including investigations of required heat exchanger characteristics to transfer this heat from the pressurized He II bath to the saturated He II system. This paper discusses heat exchangers both external to the magnet cold mass and internal to the magnet cold mass. A possible design for a heat exchanger external to the magnet cold mass is also presented.
Study on essential drug use status and its influencing factors among cerebral infarction inpatients in county level hospitals of Anhui Province, China
Background and purpose Drug costs is one of the main components of hospitalization expenditure for cerebral infarction inpatients. In China, the National Essential Medicine System (NEMS) was created to relieve the heavy drug-cost burden for patients. The objective of this study was to investigate essential drug-use status and its influencing factors among cerebral infarction inpatients in county-level hospitals of Anhui province, China. Methods Three county-level hospitals were selected through a multi-stage cluster random sampling method. The hospitalization cost data of cerebral infarction inpatients in the three hospitals were extracted from the Anhui provincial information platform of the New Rural Cooperative Insurance System (NCMS), and whether the proportion of essential drug cost in the total drug cost reached the median value of 33.05% which was set as the evaluation index for essential drug-use status. Questionnaires for hospitals and physicians were designed and given to them to assess influencing factors. Results We retrieved the cost data of 2,189 inpatients from the NCMS platform and investigated 51 corresponding physicians in total. The drug costs accounted for 52.6% of the total hospitalization cost, and essential drug costs alone accounted for 37.0% of the total drug costs. The essential drug-cost proportion was high among physicians with a higher recognition degree on NEMS, older age, lower final academic degree, longer work experience and lower professional title. Married physicians and those with tight organizational affiliation also prescribed more essential drugs. Conclusions Increasing the proportion of essential drugs was an effective way to reduce the disease burden for cerebral infarction patients. Perfecting the NEMS, increasing government investment, reinforcing education and propaganda, and formulating relevant incentive and restrictive mechanisms were all effective ways to promote and increase the number of essential drug prescriptions written by physicians.